20 May 2013
Keywords: kyowa, accelerates, drug, development, japan, hakko, kogyo
Article | 13 November 2006
Japan's Kyowa Hakko Kogyo is accelerating the clinical development of its antibody drugs in the USA. BIW-8405, an interleukin-5 receptor ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 November 2006
6 November 2006
20 November 2006
© 2013 thepharmaletter.com